Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$165.67 - $199.94 $1.48 Million - $1.79 Million
-8,941 Reduced 2.38%
366,073 $61.9 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $81,171 - $107,248
536 Added 0.14%
375,014 $74 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $380,410 - $438,744
-2,276 Reduced 0.6%
374,478 $65.2 Million
Q2 2023

Aug 09, 2023

SELL
$160.94 - $186.23 $998,793 - $1.16 Million
-6,206 Reduced 1.62%
376,754 $64.9 Million
Q1 2023

May 08, 2023

SELL
$145.48 - $175.02 $151,590 - $182,370
-1,042 Reduced 0.27%
382,960 $63.7 Million
Q4 2022

Feb 14, 2023

SELL
$131.14 - $157.47 $16.8 Million - $20.2 Million
-128,243 Reduced 25.04%
384,002 $56.3 Million
Q3 2022

Nov 07, 2022

BUY
$148.29 - $182.55 $305,922 - $376,600
2,063 Added 0.4%
512,245 $76 Million
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $1.9 Million - $2.44 Million
12,194 Added 2.45%
510,182 $87.7 Million
Q1 2022

May 12, 2022

BUY
$181.39 - $234.03 $447,851 - $577,820
2,469 Added 0.5%
497,988 $93.9 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $690,311 - $880,414
3,564 Added 0.72%
495,519 $121 Million
Q3 2021

Nov 10, 2021

BUY
$189.29 - $209.69 $1.35 Million - $1.5 Million
7,138 Added 1.47%
491,955 $95.5 Million
Q2 2021

Aug 11, 2021

BUY
$155.9 - $187.99 $43,807 - $52,825
281 Added 0.06%
484,817 $90.4 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $3.81 Million - $4.48 Million
26,434 Added 5.77%
484,536 $76.5 Million
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $5.79 Million - $6.42 Million
-36,844 Reduced 7.44%
458,102 $75.8 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $16 Million - $19.3 Million
-116,633 Reduced 19.07%
494,946 $80.4 Million
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $106 Million - $135 Million
-944,513 Reduced 60.7%
611,579 $80.7 Million
Q1 2020

May 11, 2020

BUY
$92.66 - $144.94 $58.2 Million - $91.1 Million
628,469 Added 67.75%
1,556,092 $197 Million
Q4 2019

Feb 07, 2020

BUY
$116.25 - $133.25 $1.16 Million - $1.33 Million
9,948 Added 1.08%
927,623 $123 Million
Q3 2019

Nov 04, 2019

BUY
$112.57 - $128.43 $2.34 Million - $2.67 Million
20,764 Added 2.32%
917,675 $114 Million
Q2 2019

Aug 05, 2019

BUY
$97.98 - $114.28 $4.27 Million - $4.98 Million
43,583 Added 5.11%
896,911 $102 Million
Q1 2019

May 01, 2019

BUY
$81.56 - $100.67 $1.7 Million - $2.1 Million
20,868 Added 2.51%
853,328 $85.9 Million
Q4 2018

Feb 11, 2019

BUY
$79.28 - $95.27 $19.3 Million - $23.3 Million
244,048 Added 41.48%
832,460 $71.2 Million
Q3 2018

Nov 08, 2018

BUY
$83.5 - $93.23 $103,790 - $115,884
1,243 Added 0.21%
588,412 $53.9 Million
Q2 2018

Aug 07, 2018

SELL
$79.9 - $89.2 $35.5 Million - $39.6 Million
-443,764 Reduced 43.04%
587,169 $50 Million
Q1 2018

May 09, 2018

BUY
$71.51 - $84.69 $11.2 Million - $13.3 Million
156,834 Added 17.94%
1,030,933 $86.1 Million
Q4 2017

Feb 09, 2018

BUY
$63.24 - $72.8 $4.17 Million - $4.8 Million
65,939 Added 8.16%
874,099 $63.1 Million
Q3 2017

Nov 09, 2017

BUY
$59.73 - $65.4 $48.3 Million - $52.9 Million
808,160
808,160 $51.5 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.